These products are not intended to diagnose, prevent, treat, or cure any disease
For the best results, we encourage you to adopt a healthy diet and exercise regimen
When considering any medication, it is crucial to understand the potential side effects
The article points to people with higher baseline BMI, insulin resistance, or type 2 diabetes as the group most likely to see rapid early loss, and says those with a normal BMI or less insulin resistance usually change more slowly
Because they have personally experienced a reduced desire for food, they are more likely to anticipate a decline in overall demand, translating into lower revenues and profitability expectations for restaurants, grocery stores, and food manufacturers
Semaglutide is a GLP-1 receptor agonist, while tirzepatide acts as a dual agonist for the GLP-1 and GIP receptors